A cell binding domain from the alpha 3 chain of type IV collagen inhibits proliferation of melanoma cells

被引:78
|
作者
Han, J
Ohno, N
Pasco, S
Monboisse, JC
Borel, JP
Kefalides, NA
机构
[1] UNIV PENN,UNIV CITY SCI CTR,CTRI,DEPT MED,PHILADELPHIA,PA 19104
[2] UNIV REIMS,CNRS EP89,BIOCHEM LAB,F-51095 REIMS,FRANCE
关键词
D O I
10.1074/jbc.272.33.20395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our previous studies have shown that a peptide corresponding to the residue sequence 185-203 of the NC1 domain of the alpha 3 chain of basement membrane collagen (type IV) inhibits the activation of polymorphonuclear leukocytes. Peptides from the same region of the alpha 1, alpha 2, alpha 4, and alpha 5(TV) chains did not exhibit this property, Because of the intimate relationship between metastasizing neoplastic cells and vascular as well as epithelial basement membranes, we measured the cell adhesion-promoting activity of peptides from the NC1 domain of type IV collagen and their effect on proliferation of human melanoma cells, We found that peptide alpha 3(IV)185-203 (CNYYSNSYSFWLASLNPER) not only promotes adhesion of human melanoma cells but also inhibits their proliferation. Adhesion increased by 50-60% over control. Melanoma cell proliferation was inhibited by 40% when cells were grown in a medium containing 5 mu g/ml peptide for 5 days, Studies showed that replacement of serine in position 189 or 191 by alanine resulted in significantly reduced adhesion. Similarly, serine replace ment resulted in reduced ability to inhibit proliferation. Our data suggest that a region of the NC1 domain of the alpha 3(TV) chain, contained within the sequence 185-203, not-only specifically promotes adhesion but also inhibits proliferation of melanoma cells. These properties appear to be dependent on the presence of the triplet sequence -SNS- (residues 189-191), which is unique to the alpha 3 chain and may represent an important functional epitope.
引用
收藏
页码:20395 / 20401
页数:7
相关论文
共 50 条
  • [1] The α3 chain of type IV collagen inhibits tumor cell proliferation and angiogenesis
    Shahan, TA
    Grant, DS
    Ohno, N
    Ziaie, Z
    Delisser, H
    Albelda, S
    Mousa, S
    Kefalides, NA
    [J]. VASCULAR ENDOTHELIUM: SOURCE AND TARGET OF INFLAMMATORY MEDIATORS, 2001, 330 : 316 - 317
  • [2] A specific sequence of the noncollagenous domain of the α3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells
    Pasco, S
    Han, J
    Gillery, P
    Bellon, G
    Maquart, FX
    Borel, JP
    Kefalides, NA
    Monboisse, JC
    [J]. CANCER RESEARCH, 2000, 60 (02) : 467 - 473
  • [3] Cloning, sequencing and expression of the NCl domain of the alpha 3 chain of rat type IV collagen
    Ryan, JJ
    Mason, PJ
    Turner, AN
    Pusey, CD
    [J]. IMMUNOLOGY, 1996, 89 : Q170 - Q170
  • [4] The α3 chain of type IV collagen inhibits tumor cell proliferation through cd47 and the integrin αvβ3.
    Shahan, TA
    Pasco, S
    Fawzi, A
    Monboisse, JC
    Bellon, G
    Kefalides, NA
    [J]. FASEB JOURNAL, 1999, 13 (07): : A1404 - A1404
  • [5] Oncothanin, a peptide from the α3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis
    Shahan, T
    Grant, D
    Tootell, M
    Ziaie, Z
    Ohno, N
    Mousa, S
    Mohamad, S
    Delisser, H
    Kefalides, N
    [J]. CONNECTIVE TISSUE RESEARCH, 2004, 45 (03) : 151 - 163
  • [6] Suppression of tumor cell growth by type iv collagen and a peptide from the NC1 domain of the α3(IV) chain
    Kefalides, NA
    Monboisse, JC
    Bellon, G
    Ohno, N
    Ziaie, Z
    Shahan, TA
    [J]. MEDICINA-BUENOS AIRES, 1999, 59 (05) : 553 - 553
  • [7] NEMO-binding domain peptide inhibits proliferation of human melanoma cells
    Ianaro, Angela
    Tersigni, Mariaroberta
    Belardo, Giuseppe
    Di Martino, Silvana
    Napolitano, Maria
    Palmieri, Giuseppe
    Sini, MariaCristina
    De Maio, Anna
    Ombra, MariaNeve
    Gentilcore, Giuseppina
    Capone, Mariaelena
    Ascierto, MariaLibera
    Satriano, Rocco Alfredo
    Farina, Benedetta
    Faraone-Mennella, MariaRosaria
    Ascierto, Paolo Antonio
    Ialenti, Armando
    [J]. CANCER LETTERS, 2009, 274 (02) : 331 - 336
  • [8] INVESTIGATION ON THE DIFFERENCE EXPRESSION OF TYPE IV COLLAGEN alpha 1(IV)- alpha 6(IV) CHAIN MRNA IN NORMAL FIBROBLAST AND IN SKIN CELL MALIGNANT MELANOMA
    Mohammad, Mardhiah
    Yusof, Afzan Mat
    Mohideen, Syahirah Kaja
    Bahrom, Sharifah Norbaizura Syed
    Roshdi, Ridhwan
    Parman, Adibah
    [J]. JURNAL TEKNOLOGI, 2015, 77 (25): : 141 - 145
  • [9] Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator
    Lauer, JL
    Furcht, LT
    Fields, GB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (19) : 3077 - 3084
  • [10] BINDING DOMAIN FOR LAMININ ON TYPE-IV COLLAGEN
    RAO, CN
    MARGULIES, IMK
    LIOTTA, LA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (01) : 45 - 52